Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2018 3
2019 1
2020 3
2021 4
2022 4
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19-Associated Pneumonia: Radiobiological Insights.
François S, Helissey C, Cavallero S, Drouet M, Libert N, Cosset JM, Deutsch E, Meziani L, Chargari C. François S, et al. Among authors: meziani l. Front Pharmacol. 2021 May 25;12:640040. doi: 10.3389/fphar.2021.640040. eCollection 2021. Front Pharmacol. 2021. PMID: 34113249 Free PMC article. Review.
Radio-induced lymphopenia in the era of anti-cancer immunotherapy.
de Kermenguy F, Meziani L, Mondini M, Clémenson C, Morel D, Deutsch E, Robert C. de Kermenguy F, et al. Among authors: meziani l. Int Rev Cell Mol Biol. 2023;378:1-30. doi: 10.1016/bs.ircmb.2023.03.002. Epub 2023 Apr 3. Int Rev Cell Mol Biol. 2023. PMID: 37438014 Review.
KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner.
Laurent PA, Milic M, Quevrin C, Meziani L, Liu W, Morel D, Signolle N, Clémenson C, Levy A, Mondini M, Deutsch E. Laurent PA, et al. Among authors: meziani l. J Transl Med. 2023 Oct 31;21(1):773. doi: 10.1186/s12967-023-04619-0. J Transl Med. 2023. PMID: 37907934 Free PMC article.
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.
Levy A, Morel D, Texier M, Sun R, Durand-Labrunie J, Rodriguez-Ruiz ME, Racadot S, Supiot S, Magné N, Cyrille S, Louvel G, Massard C, Verlingue L, Bouquet F, Bustillos A, Bouarroudj L, Quevrin C, Clémenson C, Mondini M, Meziani L, Tselikas L, Bahleda R, Hollebecque A, Deutsch E. Levy A, et al. Among authors: meziani l. Mol Cancer. 2024 Mar 23;23(1):61. doi: 10.1186/s12943-024-01970-8. Mol Cancer. 2024. PMID: 38519913 Free PMC article. Clinical Trial.
Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses.
Almeida A, Godfroid C, Leavitt RJ, Montay-Gruel P, Petit B, Romero J, Ollivier J, Meziani L, Sprengers K, Paisley R, Grilj V, Limoli CL, Romero P, Vozenin MC. Almeida A, et al. Among authors: meziani l. Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):1110-1122. doi: 10.1016/j.ijrobp.2023.10.031. Epub 2023 Nov 10. Int J Radiat Oncol Biol Phys. 2024. PMID: 37951550 Free PMC article.
22 results